ZBH
Zimmer Biomet Holdings Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.03% · Russell 1000 0.02% · Russell 3000 0.02% · US Stock Market 0.02% · MSCI World 0.02% · MSCI ACWI 0.02%$95.36+1.18%
as of market close, Sep 18, 2026
☀ Pre $96.20 +0.88%
ZBH financial statements
The full income statement, balance sheet, and cash-flow statement for Zimmer Biomet Holdings Inc. (ZBH), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 203.7M2024-09 199.1M2024-12 199.1M2025-03 197.8M2025-06 198.1M2025-09 198.2M2025-12 195.7M2026-03 193.5M2026-06 190.7M-6.3% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 8.23B+7.2% | 7.68B+3.8% | 7.39B+6.5% | 6.94B+1.6% | 6.83B+11.4% | |
| Cost of revenue | 2.49B+13.8% | 2.19B+5.2% | 2.08B+3.2% | 2.02B+3.0% | 1.96B+7.5% | |
| Research & development | 459M+4.8% | 437M-4.6% | 459M+13.0% | 406M-6.8% | 436M+35.0% | |
| Selling, general & administrative | 3.26B+11.2% | 2.93B+3.2% | 2.84B+2.8% | 2.76B-2.9% | 2.84B+4.8% | |
| Restructuring | — | — | — | — | 32.1M | |
| Amortization of intangibles | 666M+12.5% | 592M+5.4% | 562M+6.6% | 527M-0.5% | 530M+3.4% | |
| Operating income | 1.10B-14.6% | 1.29B+0.6% | 1.28B+83.5% | 696M-19.1% | 860M+935.3% | |
| Net interest income | -293M-34.3% | -218M-8.3% | -201M-22.1% | -165M+20.9% | -208M+1.7% | |
| Other non-operating income | 25.5M+182.0% | -31.1M-234.4% | -9.30M+92.7% | -128M-1149.2% | 12.2M-48.7% | |
| Pre-tax income | 831M-19.9% | 1.04B-2.9% | 1.07B+164.5% | 404M-19.1% | 499M+574.3% | |
| Income tax | 126M-4.3% | 131M+211.4% | 42.2M-62.4% | 112M+109.9% | 53.5M+155.7% | |
| 705M-22.0% | 904M-11.7% | 1.02B+342.5% | 231M-42.4% | 402M+389.1% | ||
| Income from continuing operations | — | 904M-11.7% | 1.02B+252.9% | 290M-34.8% | 445M+4258.9% | |
| Discontinued operations | — | — | — | -58.8M-35.5% | -43.4M+66.1% | |
| Net income to non-controlling interest | — | — | — | — | 500K-66.7% | |
| $3.55-19.9% | $4.43-9.2% | $4.88+343.6% | $1.10-42.4% | $1.91+385.1% | ||
| EPS (basic) | $3.56-20.0% | $4.45-9.4% | $4.91+346.4% | $1.10-43.0% | $1.93+388.1% | |
| Weighted-avg shares (basic) | 198M-2.5% | 203M-2.7% | 209M-0.4% | 210M+0.5% | 209M+0.8% | |
| Weighted-avg shares (diluted) | 199M-2.6% | 204M-2.8% | 210M-0.3% | 210M-0.0% | 210M+1.6% | |
| Dividends per share | $0.96+0.0% | $0.96+0.0% | $0.96+0.0% | $0.96+0.0% | $0.96+0.0% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 5.12B+9.6% | 4.67B+1.3% | 4.61B+4.1% | 4.43B-9.4% | 4.88B-3.9% | ||
| Cash & equivalents | 592M+12.6% | 526M+26.4% | 416M+10.7% | 376M-0.6% | 378M-52.9% | |
| Accounts receivable | 1.70B+15.1% | 1.48B+2.7% | 1.44B+4.4% | 1.38B+9.7% | 1.26B-13.3% | |
| Inventory | 2.29B+2.3% | 2.24B-6.3% | 2.39B+11.1% | 2.15B-0.0% | 2.15B-12.4% | |
| Prepaid expenses | 537M+24.9% | 430M+17.5% | 366M-30.0% | 523M+93.0% | 271M+60.4% | |
| 23.1B+8.1% | 21.4B-0.6% | 21.5B+2.0% | 21.1B-10.2% | 23.5B-3.9% | ||
| Property, plant & equipment | 2.21B+7.7% | 2.05B-0.6% | 2.06B+10.0% | 1.87B+2.0% | 1.84B-10.3% | |
| Operating lease right-of-use | 204M-4.4% | 214M+4.8% | 204M+3.8% | 196M-10.5% | 219M-20.1% | |
| Goodwill | 9.95B+11.1% | 8.95B+1.5% | 8.82B+2.8% | 8.58B-3.8% | 8.92B-0.7% | |
| Intangible assets | 4.72B+2.6% | 4.60B-5.3% | 4.86B-4.1% | 5.06B-8.5% | 5.53B-21.6% | |
| Other non-current assets | 1.10B+0.4% | 1.10B-4.9% | 1.15B+2.7% | 1.12B+11.7% | 1.00B+3.7% | |
| 2.58B+5.4% | 2.45B-14.2% | 2.86B+21.2% | 2.36B-32.0% | 3.47B+35.6% | ||
| Accounts payable | 303M+55.7% | 195M-52.6% | 411M+16.0% | 354M+15.5% | 307M-7.1% | |
| Accrued liabilities | 835M+18.1% | 707M-12.1% | 804M+38.0% | 582M+8.6% | 536M-38.6% | |
| Short-term & current debt | 587M-32.0% | 863M-4.1% | 900M+65.3% | 544M-66.1% | 1.61B+221.0% | |
| Current lease liability | 57.5M+8.1% | 53.2M+0.6% | 52.9M-0.2% | 53.0M-6.5% | 56.7M-24.4% | |
| Other current liabilities | 1.22B-12.7% | 1.39B-9.9% | 1.55B+8.8% | 1.42B+7.9% | 1.32B-21.0% | |
| 10.4B+16.8% | 8.89B-1.3% | 9.01B-0.3% | 9.04B-16.2% | 10.8B-11.7% | ||
| Long-term debt | 6.93B+29.8% | 5.34B+9.7% | 4.87B-5.5% | 5.15B-5.7% | 5.46B-28.4% | |
| Non-current lease liability | 176M-7.7% | 190M+9.1% | 174M+4.2% | 167M-4.3% | 175M-19.7% | |
| Operating lease liability (total) | 233M-4.3% | 243M+7.1% | 227M+3.2% | 220M-23.9% | 290M-1.1% | |
| Deferred tax liabilities | 244M-30.8% | 353M-1.4% | 358M-24.7% | 475M-15.0% | 559M-29.3% | |
| Other non-current liabilities | 626M-15.9% | 744M-19.6% | 926M+46.3% | 633M+15.3% | 549M-16.4% | |
| 12.7B+1.8% | 12.5B-0.1% | 12.5B+3.8% | 12.0B-5.1% | 12.7B+3.8% | ||
| Common stock | 3.20M+0.0% | 3.20M+0.0% | 3.20M+3.2% | 3.10M+0.0% | 3.10M+0.0% | |
| Additional paid-in capital | 10.2B+1.4% | 10.0B+2.0% | 9.85B+3.6% | 9.50B+2.0% | 9.31B+2.1% | |
| Retained earnings | 11.6B+4.6% | 11.1B+6.8% | 10.4B+8.6% | 9.56B-7.1% | 10.3B+2.0% | |
| Treasury stock | 8.89B+5.8% | 8.41B+11.2% | 7.56B+10.1% | 6.87B+2.2% | 6.72B-0.0% | |
| Accumulated other comprehensive income | -206M+21.7% | -263M-37.6% | -191M-6.5% | -179M+22.6% | -232M+22.2% | |
| Non-controlling interest | 8.10M+0.0% | 8.10M+5.2% | 7.70M+14.9% | 6.70M+17.5% | 5.70M+9.6% | |
| Total equity incl. non-controlling | 12.7B+1.8% | 12.5B-0.1% | 12.5B+3.8% | 12.0B-5.0% | 12.7B+3.8% | |
| Total liabilities & equity | 23.1B+8.1% | 21.4B-0.6% | 21.5B+2.0% | 21.1B-10.2% | 23.5B-3.9% | |
| Common shares issued | 319M+0.4% | 318M+0.4% | 316M+0.8% | 314M+0.3% | 313M+0.4% | |
| Common shares outstanding | 319M+0.4% | 318M+0.4% | 316M+0.8% | 314M+0.3% | 313M+0.4% | |
| Shares outstanding (cover) | 196M-1.7% | 199M-2.9% | 205M-1.9% | 209M-0.1% | 209M+0.6% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 1.70B+13.2% | 1.50B-5.2% | 1.58B+16.6% | 1.36B-9.5% | 1.50B+24.5% | ||
| Depreciation & amortization | 1.09B+9.8% | 996M+4.7% | 952M+2.7% | 926M-1.2% | 938M+4.4% | |
| Intangible amortization | 666M+12.5% | 592M+5.4% | 562M+6.6% | 527M-0.5% | 530M+3.4% | |
| Share-based compensation | 90.2M-10.7% | 101M+1.2% | 99.8M-5.0% | 105M+38.2% | 76.0M+3.0% | |
| Deferred income taxes | -87.2M-82.8% | -47.7M+50.5% | -96.3M-49.5% | -64.4M+36.9% | -102M-359.1% | |
| Change in inventory | -98.2M-96.8% | -49.9M-120.8% | 240M+218.0% | 75.6M+800.0% | 8.40M-75.7% | |
| -1.98B-122.5% | -888M-14.0% | -779M | — | -504M+18.0% | ||
| Capital expenditure | 225M+10.2% | 204M-30.0% | 291M+54.9% | 188M+30.8% | 144M+28.3% | |
| Free cash flow | 1.47B+13.7% | 1.30B+0.4% | 1.29B+10.5% | 1.17B-13.8% | 1.36B+24.1% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other investing activities | 4.60M-87.5% | 36.9M+228.1% | -28.8M-180.7% | 35.7M+82.1% | 19.6M-1.0% | |
| 326M+167.3% | -485M+36.5% | -764M | — | -1.31B-209.6% | ||
| Long-term debt issued | 2.49B+73.5% | 1.44B+187.4% | 500M | 0.00-100.0% | 1.60B+6.9% | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 487M-43.9% | 868M+25.4% | 692M+447.6% | 126M | 0.00 | |
| Dividends paid | 190M-2.9% | 196M-2.4% | 201M-0.1% | 201M+0.5% | 200M+0.8% | |
| Other financing activities | -17.7M+21.0% | -22.4M-121.8% | -10.1M-124.4% | -4.50M+28.6% | -6.30M+24.1% | |
| Net change in cash | 66.4M-39.5% | 110M+173.6% | 40.1M+139.0% | -103M+68.2% | -324M-275.7% | |
| Interest paid | 298M+48.6% | 201M+0.1% | 201M+24.1% | 162M-26.2% | 219M+13.4% | |
| Income taxes paid | 377M+14.7% | 329M+52.6% | 215M-34.1% | 327M+26.4% | 258M+82.0% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 17.6B-16.3% | 21.0B-17.3% | 25.4B-4.9% | 26.8B+3.7% | 25.8B-17.0% | |
| P/E | 25.0×+7.2% | 23.3×-56.6% | 53.6×-44.3% | 96.3×+49.9% | 64.2× | |
| P/S | 2.1×-22.0% | 2.7×-21.6% | 3.5×-10.0% | 3.9×+2.7% | 3.8×-25.5% | |
| P/B | 1.4×-17.8% | 1.7×-17.0% | 2.0×-7.0% | 2.2×+7.2% | 2.0×-20.1% | |
| P/FCF | 11.9×-26.4% | 16.2×-39.7% | 26.9×+36.3% | 19.7×+3.7% | 19.0×-33.1% | |
| Earnings yield | 4.0%-6.8% | 4.3%+130.5% | 1.9%+79.6% | 1.0%-33.3% | 1.6% | |
| FCF yield | 8.4%+35.8% | 6.2%+65.7% | 3.7%-26.6% | 5.1%-3.6% | 5.3%+49.5% | |
| Dividend yield | 1.1%+17.5% | 0.91%+15.2% | 0.79%+4.8% | 0.75%-3.3% | 0.78%+21.3% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: ZBH’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ZBH filings on SEC EDGAR → Not investment advice.